Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $416 Billion
  • Q2 2025

Artia Global Partners LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $416 Billion distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $87.4B, Insmed Inc with a value of $75.8B, Argenx Se with a value of $43.2B, Soleno Therapeutics Inc with a value of $41.4B, and Eli Lilly & CO with a value of $23.9B.

Examining the 13F form we can see an increase of $20.5B in the current position value, from $395B to 416B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $416 Billion
Healthcare: $357 Billion
ETFs: $14.1 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$207M
$1.29 Billion 0.31% of portfolio
475,361
Q2 2025 Added 12.82%

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $416 Billion
  • Prior Value $395 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 10 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email